If a person with schizophrenia is exhausted during the day, the easy explanation is the medication. Sometimes that's correct. But often, hiding underneath sedation, there is something else: obstructive sleep apnea (OSA), a condition where the upper airway repeatedly collapses during sleep, leading to brief awakenings, low oxygen, and fragmented rest. OSA is several times more common in schizophrenia than in the general population — and it is one of the most under-diagnosed contributors to fatigue, cognitive slowing, and metabolic decline in this population.
Sleep apnea is common in schizophrenia, frequently mistaken for medication side effects, and treatable in ways that meaningfully improve daytime energy, cognition, and cardiovascular risk.
How common is it?
A 2019 systematic review in Sleep Medicine Reviews by Stubbs and colleagues found that OSA prevalence in schizophrenia was around 15–48% depending on the screening method, considerably higher than the 4–9% commonly cited for the general adult population. Even using strict criteria, OSA appears to be several times more prevalent than in matched controls.
Why the risk is higher
- Weight gain: antipsychotics, particularly olanzapine, clozapine, and quetiapine, increase weight and abdominal fat — both major OSA risk factors
- Sedation: many antipsychotics suppress upper airway muscle tone during sleep, worsening collapsibility
- Smoking: also more common in schizophrenia, contributes to upper airway inflammation
- Lower physical fitness: aerobic deconditioning makes OSA worse
Why it gets missed
The classic symptoms of OSA — snoring, daytime sleepiness, brain fog — are easily attributed to "the meds." Family members are also less likely to flag the snoring as concerning when so many other things feel more pressing. Add to that the fact that polysomnography (overnight sleep studies) is logistically demanding, and most clinics never get to the question.
What to watch for
- Loud habitual snoring
- Witnessed pauses in breathing during sleep
- Choking or gasping awakenings
- Persistent morning headaches
- Daytime sleepiness despite seemingly adequate sleep duration
- Worsening cognition, especially memory and attention
- New-onset or hard-to-control hypertension
- Dry mouth on waking
Standard screening tools include the STOP-Bang questionnaire (8 yes/no questions about snoring, tiredness, observed apnea, blood pressure, BMI, age, neck circumference, gender) and the Epworth Sleepiness Scale. Both are easy to score and can prompt a referral.
Loud snoring with witnessed breathing pauses, severe daytime sleepiness affecting safety (driving, working with machinery), or morning headaches accompanied by high blood pressure. These warrant a sleep study, not a watch-and-wait approach.
How OSA is diagnosed
Diagnosis requires a sleep study — either an in-lab polysomnogram (PSG) or a home sleep apnea test (HSAT). HSATs are increasingly common, accessible, and easier to tolerate. They measure breathing pauses, oxygen levels, and heart rate overnight. The result is reported as the apnea-hypopnea index (AHI):
- AHI 5–14: mild OSA
- AHI 15–29: moderate OSA
- AHI 30+: severe OSA
Why treating it matters
Untreated OSA in schizophrenia is associated with:
- Worse cognition (especially attention and working memory)
- Worse mood
- Higher rates of metabolic syndrome and diabetes
- Higher cardiovascular risk and arrhythmia
- Worse daytime functioning, harder participation in rehab and work
Conversely, treating OSA in this population improves daytime alertness, sometimes improves cognition, and reduces cardiometabolic risk.
Treatment options
CPAP
Continuous positive airway pressure remains the gold standard. The classic concern — that people with schizophrenia won't tolerate CPAP — is increasingly contradicted by the evidence. Adherence rates are similar to the general population when patients receive structured support, mask choice, and gradual acclimatisation. Modern CPAP machines are much quieter and smaller than they were a decade ago.
Mandibular advancement devices
For mild-to-moderate OSA, a custom oral appliance from a dentist can be effective, particularly for people who can't tolerate CPAP.
Weight loss
Even modest weight loss (5–10% of body weight) can substantially reduce OSA severity. This is one more reason to treat antipsychotic-related weight gain proactively.
Positional therapy
For people whose apnea is much worse on their back, simple positional devices that prevent supine sleep can help.
Reviewing medications
Heavy night-time sedation can worsen OSA. If a more sedating antipsychotic (or added benzodiazepine) is contributing, the prescriber may consider adjustments. Never change medication doses without input.
Practical first steps
- If the symptoms above resonate, raise the question explicitly with the primary care provider or psychiatrist
- Ask about a STOP-Bang or Epworth screening
- Request a home sleep apnea test if the screening is positive
- If diagnosed, ask for a structured CPAP support program — outcomes hinge on adherence support, not just the prescription
Tools like Frida can help track sleep quality, daytime energy, and CPAP use over weeks, giving the clinician real data to titrate against. See also our sleep hygiene guide for the broader picture.
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.